Lung cancer screening: New guidelines, new challenges

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Smoking is still the number one preventable cause of death in the U.S.​ and lung cancer is far and away the number one cause of cancer death in the U.S. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
David Balis, MD
Professor, general internal medicine, Department of Internal Medicine, UT Southwestern Medical Center; Director, Smoking Cessation Clinics, Parkland and UT Southwestern
Table of Contents

YOU MAY BE INTERESTED IN

The College of American Pathologists in collaboration with the International Association for the Study of Lung Cancer, Pulmonary Pathology Society, Association for Molecular Pathology, and the LUNGevity Foundation have developed evidence-based recommendations for the testing of immunotherapy biomarkers, including programmed cell death ligand-1 and tumor mutation burden in patients with non-small cell lung carcinoma.
David Balis, MD
Professor, general internal medicine, Department of Internal Medicine, UT Southwestern Medical Center; Director, Smoking Cessation Clinics, Parkland and UT Southwestern

Login